Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Crassocephalum rabens extract is a botanical extract derived from the aerial parts of the herb Crassocephalum rabens, traditionally used in Taiwanese folk medicine to treat inflammation-related conditions.[2][1] The extract contains a prominent active phytogalactolipid, 1,2-di-O-linolenoyl-3-O-β-galactopyranosyl-sn-glycerol (dLGG), which has demonstrated anti-oxidative, anti-inflammatory, anti-hyaluronidase, and anti-cancer activities in preclinical studies. Clinical studies suggest that this extract may improve skin health by increasing collagen content, improving skin elasticity and brightness, and reducing wrinkles and UV spots in healthy adults.[1][2] The mechanism of action is believed to involve inhibition of cyclooxygenase-2 (COX-2) expression and matrix metalloproteinases (MMPs), leading to reduced melanin production and decreased collagen degradation.[1] It is being developed and marketed as a dietary supplement for skin aging, vitality, and physical strength, and has been researched for possible anti-cancer effects, including potential utility in breast cancer/metastasis.[1][2][4][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on crassocephalum rabens extract.